| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −18.3× | −1.7× | |
| Price / Book | 1.0× | 2.0× | |
| Price / Sales | 7.2× | 3.9× | |
| Price / Free cash flow | 74.0× | −1.6× | |
| EV / EBITDA | −20.0× | −1.2× | |
| Earnings yield | −5.5% | −14.4% | |
| Free cash flow yield | 1.4% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,240.34 | −1.33% | $1.17T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $253.79 | −0.69% | $611.61B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $282.68 | −0.96% | $499.53B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $406.88 | +1.36% | $365.21B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $143.63 | −1.59% | $354.36B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.20 | −0.28% | $276.89B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $163.95 | −0.88% | $254.27B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $679.38 | −1.54% | $251.2B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $424.94 | −1.75% | $229.74B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $153.07 | −2.00% | $189.8B | 22.3× | 37.5% | +29.9% |
